Testing effectiveness (Phase 2)UnknownNCT03612154What this trial is testingStudy of Lorlatinib in ROS1 Rearranged NSCLCWho this might be right forNonsmall Cell Lung Cancer National Cancer Center, Korea 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT05888831What this trial is testingBMS-986449 With and Without Nivolumab in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Bristol-Myers Squibb 100
Testing effectiveness (Phase 2)Looking for participantsNCT06538012What this trial is testingTIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung CancerWho this might be right forLung CancerLung Cancer MetastaticLung Cancer, Non-small Cell+1 more Essen Biotech 85
Testing effectiveness (Phase 2)UnknownNCT03119519What this trial is testingLocal Non-salvage Radiotherapy for Synchronous Oligometastatic Non-small-cell Lung Cancer.Who this might be right forStage IV Non-small Cell Lung Cancer Southern Medical University, China 148
Early research (Phase 1)UnknownNCT05580172What this trial is testingPhase 1 Study of Oral RH324 in Advanced Non-Small Cell Lung CancerWho this might be right forSafety Issues ReHeva Biosciences,Inc. 6
Not applicableActive Not RecruitingNCT01888601What this trial is testingTRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)Who this might be right forNon-small Cell Lung Cancer University College, London 814
Testing effectiveness (Phase 2)Study completedNCT03129256What this trial is testingAn Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Changzhou Cancer Hospital of Soochow University 52
Testing effectiveness (Phase 2)Study completedNCT01048645What this trial is testingEffect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung CancerWho this might be right forNon-Small-Cell Lung Carcinoma National Institute of Cancerología 107
Large-scale testing (Phase 3)Looking for participantsNCT06452277What this trial is testingLearn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Who this might be right forAdvanced Non-small Cell Lung Cancer, HER2 Mutation Bayer 555
Not applicableStudy completedNCT04667312What this trial is testingObservational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United KingdomWho this might be right forNon-Small Cell Lung Cancer NSCLC AstraZeneca 115
Large-scale testing (Phase 3)Looking for participantsNCT07182682What this trial is testingSunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical SurgeryWho this might be right forNon-Small Cell Lung Cancer Dizal (Jiangsu) Pharmaceutical Co., Ltd. 360
Early research (Phase 1)Ended earlyNCT04458259What this trial is testingStudy of PF-07265807 in Participants With Metastatic Solid Tumors.Who this might be right forNeoplasm Metastasis Pfizer 88
Post-approval studies (Phase 4)Ended earlyNCT04381494What this trial is testingMobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.Who this might be right forUnresectable Stage III NSCLC AstraZeneca 40
Testing effectiveness (Phase 2)UnknownNCT01131429What this trial is testingA Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR MutationsWho this might be right forNeoplasms, LungCarcinoma, Non-Small Cell LungDrug Therapy+1 more Chinese PLA General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01004731What this trial is testingStudy of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung CancerWho this might be right forStage IV Non-Small Cell Lung Cancer University of Alabama at Birmingham 7
Testing effectiveness (Phase 2)WithdrawnNCT05481775What this trial is testingEvaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung CancerWho this might be right forLocally Advanced Non-small Cell Lung CancerEfficacy and Safety Sun Yat-sen University
Early research (Phase 1)Ended earlyNCT01886573What this trial is testingAzacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing SurgeryWho this might be right forStage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more National Cancer Institute (NCI) 40
Not applicableStudy completedNCT04105153What this trial is testingReal-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLCWho this might be right forEGFR Positive Non-small Cell Lung Cancer Thoraxklinik-Heidelberg gGmbH 400
Not applicableEnrolling By InvitationNCT06752395What this trial is testingCryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary LesionsWho this might be right forLung Cancer (NSCLC) Pusan National University Hospital 200
Large-scale testing (Phase 3)Active Not RecruitingNCT05211895What this trial is testingA Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLCWho this might be right forNon-Small Cell Lung Cancer AstraZeneca 791